Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-705-7 | CAS number: 1228186-15-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Dose descriptor:
- NOAEL
- 125 mg/kg bw/day
Additional information
One study was recorded for this endpoint and identified as a key study. The study of Bussi (1999) performed on the structural analogue Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides' (DHTDMAC) was reliable without restrictions study.
The objective of this study was to evaluate the potential reproductive/developmental toxicity of the test substance according to a GLP conform Reproduction/Developmental Toxicity Screening Test (OECD Guideline 421).
Groups of 10 rats (CRL:CD (SD) BR) per sex were treated with dosages of 0, 62.5, 125, and 500 mg/kg bw/day by gavage (administration volume 10 ml/kg bw/day) using corn oil as a vehicle for the control group. Males were treated daily from two weeks before mating, during mating and until a dosing period of a total of 28 days had been completed. Females were treated daily from two weeks before mating until the 4 th day of lactation. Subsequently these females weresacrificedwith their pups.
At daily doses of 500 mg/kg bw one male and one female died after 12 respectively 10 treatments. Clinical observations revealed dyspnea, soft stools in all females and almost all males. Half of the females also showed slight to moderate dilation of the abdomen. Body weight loss of about 14 to 15 g was observed in both sexes during the first week of treatment. Further, statistically significantly lower mean daily food consumption was observed in the males during the premating period and in the dams during the first week of pregnancy. Statistically significantly lower mean dam body weights were observed after 14 and 20 days of gestation and at the day of birth after delivery.
No toxicologically relevant effects were observed at dosages of 125 and 62.5 mg/kg bw/day.
At sacrifice of the parental animals no significant differences were found on the organ weights of uterus, ovaries, testes and epididymides. Histopathology of testes, epididymides and of the ovaries of the animals of the 500 mg/kg dose groups were reported not show any compound related changes. No substance related changes were reported for the evaluation of testicular stages of spermatogenesis performed in the PAS-hematoxylin stained sections.
At 500 mg/kg/day, from the 9 paired females 7 revealed to be sperm positive (77 %) after mating, 6 out of 9 (67 %) revealed to be pregnant, and 5 out of 6 (83 %) delivered live litters. One animal revealed to have fully resorbed. Mean pre-coital time was longer in this group (about 6.1 days) when compared to the controls and the lower dosage groups (1.5 to 2.1 days).
At the dosages of 62.5 and 125 mg/kg/day all of the 10 paired females revealed to be sperm positive after mating, all revealed to be pregnant and all delivered live litters. The numbers of corpora lutea had not been evaluated during this study.
At 500 mg/kg/day, from the 9 paired females 7 revealed to be sperm positive (77 %) after mating, 6 out of 9 (67 %) revealed to be pregnant, and 5 out of 6 (83 %) delivered live litters. One animal revealed to have fully resorbed. Mean pre-coital time was longer in this group (about 6.1 days) when compared to the controls and the lower dosage groups (1.5 to 2.1 days).
After birth, for the animals treated with 62.5 or 125 mg/kg/day there were no substance related biological differences in their pregnancy outcome in comparison to the control group.
For all dose groups under investigation no statistically significant differences were found for the body weights of male and female pups at birth and on postnatal day 4.
The No-observed-adverse-effect level (NOAEL)/reproductive toxicity: 125 mg/kg bw/day.
Short description of key information:
The potential reproductive/developmental toxicity of the substance was assessed using:
-a reproductive/developmental screening test performed in rats with the structural analogue 'Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides' according to OECD guideline 421 and Good Laboratory Practices (Bussy, 1999).
During this study clear signs of general toxicity were observed after repeated administration of 500 mg/kg/d in both sexes, a dosage which led to impaired reproductive performance. Based on the reduced mating, fertility and gestation indices in the 500 mg/kg/d dose group a NOAEL for reproductive toxicity of 125 mg/kg/d can be estimated from this study and used for risk assessment.
Effects on developmental toxicity
Description of key information
There are no adequate data available on Benzyl-dihydrogenatedtallowalkylmethyl ammonium chloride with regard to developmental toxicity and teratogenicity. However, read-across can be made to experimental results from the structural closely related ditallowdimethylammonium chloride. In this study no indications of developmental toxicity were observed neither by oral administration via gavage nor by oral uptake of the test compound via the diet. The NOAEL for developmental toxicity was established to be greater than 500 mg/kg body weight per day via gavage and greater than 508 mg/kg body weight per day via the diet. Although the study predates formal guidelines and GLP, a reliabilty check by an expert panel of the American Chemistry Council concluded that the study was reliable with restrictions (Klimisch 2A).
Moreover, two evaluation reports on the structural closely related DidecylDimethylAmmonium Chloride (DDAC) have been recently published by the European Competent Authorities and conclude that the substance was of no concern for developmental toxicity (Document I- Draft Evaluation reports in the frame of the directive 98/8/EC concerning the placing of biocidal products on the market - DDAC CAS 7173 -51 -5- Product type 8 - RMS Italy, July 2
Effect on developmental toxicity: via oral route
- Dose descriptor:
- NOAEL
- 500 mg/kg bw/day
Additional information
The endpoint developmental toxicity / teratogenicity is covered by read across from a respective study conducted with the structurally closely related substance 'ditallowdimethylammonium chloride' as test item instead of the substance Benzyl-dihydrogenatedtallowalkyl-methyl ammonium chloride. The former is produced by the reaction of the ditallowalkylmethylamine with methylhalide while the latter is produced by reaction of the di-C16 -C18 alkylmethylamine with the same methylhalide. Therefore the reaction products are structurally closely related and the result concerning developmental toxicity / teratogenicity for 'ditallowdimethylammonium chloride' can be extrapolated to the test substance (N-benzyl-N-C16-18(even numbered)-alkyl-N-methyl-C16-18(even numbered)-alkyl-1-aminium chloride).
Although the study of (1975) predates formal guidelines and GLP, a reliabilty check by an expert panel of the American Chemistry Council concluded that the study was reliable with restrictions (Klimisch 2A).
In this study, ditallowdimethylammonium chloride (DTDMAC) was investigated for developmental toxicity in the rat. 25 female rats per group were administered DTDMAC either by oral gavage at dose levels of 100 and 500 mg active ingredient per kg body weight per day (vehicle was 15% isopropanol) or in the diet at a dose level of 0.65% active ingredient beginning on day 6 of gestation. Two control groups were run concurrently. One received the gavage vehicle and the other received control feed only.
Ten rats per group were sacrificed after the day 13 treatment and 15 rats per group were treated through day 18 and sacrificed on day 21 of gestation. Body weights were taken on days 0, 6, 9, 12, 15, 18 and 21 of gestation. Food consumption was evaluated for days 12 and 18 of gestation. Clinical observations were made daily for signs of pharmacologic or toxicologic effect and mortality. Gross necropsies were conducted on all surviving rats, moribund rats and rats that died spontaneously. At necropsy, for rats sacrificed on day 13 of gestation, the uterus (number and location for each horn of resorptions, embryos and implantation sites) and ovaries (number of corpora lutea of pregnancy per ovary) were observed. At necropsy for rats sacrificed on day 21 of gestation, the uterus (number and location for each horn of live fetuses, dead fetuses, early and late resorptions and implantation sites) and ovaries ( number of corpora lutea of pregnancy per ovary) were observed. The necropsy for all maternal rats also included observations for obvious abnormalities and the following tissues were examined: heart, lung, stomach, liver, pancreas, spleen, mesenteric lymph nodes, jejunum, kidney, adrenal, bladder and ovary.
With regard to maternal data, no adverse effects attributable to DTDMAC administration were noted in comparison of pregnancy and mortality rates. Depressed body weight gains during gestation were noted in the group that received the test substance in the diet together with less food consumption values compared to the group that received control feed. Early deliveries and abortions, necropsy findings, and reproduction data were considered not to be affected by treatment with the test substance. An increase in resorptions was observed for the 100 mg/kg/day gavage group compared to the isopropanol control group (7.1% vs 2.1%). This difference was not considered a treatment-related effect due to the lack of dose response and a low value for the control group compared to historical data from the laboratory.
With regard to fetal data, no differences considered to be related to the administration of ditallowdimethylammonium chloride were noted in fetal size and sex, variations in degree of ossification or malformations.
Based on the results of this study, the NOAEL for maternal toxicity was considered to be greater 500 mg/kg body weight per day by gavage. No NOAEL for maternal toxicity was established for dietary treatment because of the slight effects on body weight gain. With regard to developmental toxicity the NOAEL was established to be greater 500 mg/kg body weight per day by gavage and greater 508 mg/kg body weight.
The study of Palmer (1983) is disregarded. Due to the well known very poor dermal absorption of quaternary ammonium compounds, the topical route of application is considered not to be suited for the evaluation of an inherent potential for developmental toxicity. This view is in line with the conclusions from the existing EU risk assessment on DODMACJustification for classification or non-classification
Based on the results from cross-reading to dioctadecyldimethylammonium chloride and from comparable quaternary ammonium compounds in general such as DDAC and Benzalkonium chloride, no reproductive toxicity or effects on fertility of Benzyl-dihydrogenatedtallowalkyl-methyl ammonium chloride
are anticipated. From the study performed in rat with the structural analogue ditallowdimethylammonium chloride, it is concluded thatBenzyl-dihydrogenatedtallowalkyl-methyl ammonium chloride
should not be toxic to the embryo and the fetus and shoud not be teratogenic No classification is required according to regulation 67/548/ EEC and CLP regulation(EC) N° 1272/2008.Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)